Your browser doesn't support javascript.
loading
Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice.
Jabara, Haifa H; Lee, John J; Janssen, Erin; Ullas, Sumana; Liadaki, Kyriaki; Garibyan, Lilit; Benson, Halli; Sannikova, Tatyana; Bram, Richard; Hammarstrom, Lennart; Cruz, Anthony C; Siegel, Richard; Manis, John; Malley, Richard; Geha, Raif S.
Afiliação
  • Jabara HH; Division of Immunology, Boston Children's Hospital, Boston Children's Hospital, and Harvard Medical School, Boston, Mass.
  • Lee JJ; Division of Immunology, Boston Children's Hospital, Boston Children's Hospital, and Harvard Medical School, Boston, Mass.
  • Janssen E; Division of Immunology, Boston Children's Hospital, Boston Children's Hospital, and Harvard Medical School, Boston, Mass.
  • Ullas S; Division of Immunology, Boston Children's Hospital, Boston Children's Hospital, and Harvard Medical School, Boston, Mass.
  • Liadaki K; Division of Immunology, Boston Children's Hospital, Boston Children's Hospital, and Harvard Medical School, Boston, Mass.
  • Garibyan L; Division of Immunology, Boston Children's Hospital, Boston Children's Hospital, and Harvard Medical School, Boston, Mass.
  • Benson H; Division of Immunology, Boston Children's Hospital, Boston Children's Hospital, and Harvard Medical School, Boston, Mass.
  • Sannikova T; Division of Immunology, Boston Children's Hospital, Boston Children's Hospital, and Harvard Medical School, Boston, Mass.
  • Bram R; Department of Immunology, Mayo Clinic College of Medicine, Rochester, Minn.
  • Hammarstrom L; Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
  • Cruz AC; Immunoregulation Section, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Md.
  • Siegel R; Immunoregulation Section, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Md.
  • Manis J; Division of Transfusion Medicine, Boston Children's Hospital, Boston Children's Hospital, and Harvard Medical School, Boston, Mass.
  • Malley R; Division of Infectious Diseases, Boston Children's Hospital, Boston Children's Hospital, and Harvard Medical School, Boston, Mass.
  • Geha RS; Division of Immunology, Boston Children's Hospital, Boston Children's Hospital, and Harvard Medical School, Boston, Mass. Electronic address: raif.geha@childrens.harvard.edu.
J Allergy Clin Immunol ; 139(4): 1293-1301.e4, 2017 Apr.
Article em En | MEDLINE | ID: mdl-27609654
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Pneumocócica / Proteína Transmembrana Ativadora e Interagente do CAML Tipo de estudo: Etiology_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Pneumocócica / Proteína Transmembrana Ativadora e Interagente do CAML Tipo de estudo: Etiology_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article